Stock ANTX AN2 THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions AN2 Therapeutics, Inc.

Equities

ANTX

US0373261058

Market Closed - Nasdaq
Other stock markets
 21:00:00 20/06/2024 BST 		5-day change 1st Jan Change
2.07 USD +3.50% Intraday chart for AN2 Therapeutics, Inc. +4.02% -89.90%
05-16 Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating MT
05-14 AN2 Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ANTX Stock
  4. Revisions AN2 Therapeutics, Inc.